HOMEVULNERABILITIESCVE-2026-32122
MEDIUM

CVE-2026-32122

CWE-862Published: March 11, 2026· Updated: Mar 13, 2026

4.3
CVSS v3.1
EPSS:0.07%probability of exploitation in 30 daysPercentile:21.3th

Official Description

OpenEMR is a free and open source electronic health records and medical practice management application. Prior to 8.0.0.1, the Claim File Tracker feature exposes an AJAX endpoint that returns billing claim metadata (claim IDs, payer info, transmission logs). The endpoint does not enforce the same ACL as the main billing/claims workflow, so authenticated users without appropriate billing permissions can access this data. This vulnerability is fixed in 8.0.0.1.

NVD Source

Technical Analysis

CVE-2026-32122 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityLow
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Affected Vendors & Products

open-emr1 product
openemr
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2026-32122
CVSS Score4.3 / 10
SeverityMEDIUM
WeaknessCWE-862
CISA KEVNo
EPSS (30d)0.07%
Affected1 vendor
PublishedMar 11, 2026

Related CVEs (CWE-862)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-32122 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.